Sotera Health Company

NasdaqGS:SHC 주식 보고서

시가총액: US$3.6b

Sotera Health 관리

관리 기준 확인 3/4

Sotera Health CEO는 Michael Petras, Jun2016 에 임명되었습니다 의 임기는 8.42 년입니다. 총 연간 보상은 $ 9.70M, 10.8% 로 구성됩니다. 10.8% 급여 및 89.2% 보너스(회사 주식 및 옵션 포함). 는 $ 69.35M 가치에 해당하는 회사 주식의 1.91% 직접 소유합니다. 69.35M. 경영진과 이사회의 평균 재임 기간은 각각 4.1 년과 4 년입니다.

주요 정보

Michael Petras

최고 경영자

US$9.7m

총 보상

CEO 급여 비율10.8%
CEO 임기8.4yrs
CEO 소유권1.9%
경영진 평균 재임 기간4.1yrs
이사회 평균 재임 기간4yrs

최근 관리 업데이트

Recent updates

Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable

Sep 02
Sotera Health Company's (NASDAQ:SHC) P/S Still Appears To Be Reasonable

Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Jun 25
Sotera Health (NASDAQ:SHC) Takes On Some Risk With Its Use Of Debt

Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

May 30
Sotera Health Company (NASDAQ:SHC) Shares Could Be 42% Below Their Intrinsic Value Estimate

The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Mar 21
The Price Is Right For Sotera Health Company (NASDAQ:SHC) Even After Diving 29%

Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

Mar 01
Sotera Health Company Just Missed Earnings - But Analysts Have Updated Their Models

McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount

Feb 08

Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Feb 06
Is Sotera Health (NASDAQ:SHC) A Risky Investment?

Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Dec 28
Investors Still Aren't Entirely Convinced By Sotera Health Company's (NASDAQ:SHC) Revenues Despite 26% Price Jump

Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

Dec 11
Sotera Health Company's (NASDAQ:SHC) Intrinsic Value Is Potentially 33% Above Its Share Price

An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sep 10
An Intrinsic Calculation For Sotera Health Company (NASDAQ:SHC) Suggests It's 37% Undervalued

Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jun 05
Sotera Health Company (NASDAQ:SHC) Shares Could Be 24% Below Their Intrinsic Value Estimate

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Feb 13
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 34%?

Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Nov 24
Market Participants Recognise Sotera Health Company's (NASDAQ:SHC) Earnings Pushing Shares 29% Higher

Sotera Health plunges 20% after jury awards $363M against its Sterigenics unit

Sep 19

Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

Sep 08
Are Investors Undervaluing Sotera Health Company (NASDAQ:SHC) By 49%?

CEO 보상 분석

Michael Petras 의 보수는 Sotera Health 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

US$70m

Jun 30 2024n/an/a

US$40m

Mar 31 2024n/an/a

US$55m

Dec 31 2023US$10mUS$1m

US$51m

Sep 30 2023n/an/a

-US$306m

Jun 30 2023n/an/a

-US$268m

Mar 31 2023n/an/a

-US$261m

Dec 31 2022US$17mUS$1m

-US$234m

Sep 30 2022n/an/a

US$121m

Jun 30 2022n/an/a

US$123m

Mar 31 2022n/an/a

US$135m

Dec 31 2021US$2mUS$1m

US$115m

Sep 30 2021n/an/a

US$36m

Jun 30 2021n/an/a

US$9m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$17mUS$728k

-US$39m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$29m

Dec 31 2019US$2mUS$700k

-US$21m

보상 대 시장: Michael 의 총 보상 ($USD 9.70M )은 US 시장( $USD 6.56M ).

보상과 수익: Michael 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Michael Petras (55 yo)

8.4yrs

테뉴어

US$9,701,005

보상

Mr. Michael B. Petras Jr., serves as Chief Executive Officer at Sotera Health Company since June 20, 2016. He has been Chairman of the Board at Sotera Health Company since October 2020. He also served as t...


리더십 팀

이름위치테뉴어보상소유권
Michael Petras
Chairman & CEO8.4yrsUS$9.70m1.91%
$ 69.3m
Jonathan Lyons
Senior VP & CFO1.4yrsUS$2.18m0.039%
$ 1.4m
Alexander Dimitrief
Senior VP2yrsUS$862.18k0.083%
$ 3.0m
Michael Rutz
President of Sterigenics4.1yrsUS$2.03m0.17%
$ 6.1m
Robert Hauzie
Chief Information Officer5.8yrs데이터 없음데이터 없음
Kristin Gibbs
Chief Marketing Officer8yrs데이터 없음데이터 없음
William Lehmann
Senior Vice President of Strategy & Corporate Development2.8yrs데이터 없음데이터 없음
Sally Turner
Chief Human Resources Officer5.8yrs데이터 없음데이터 없음
Danielle Menture
Senior Vice President of Global Environmentalless than a year데이터 없음데이터 없음
Joseph Shrawder
President of Nelson Labs4.1yrs데이터 없음데이터 없음
Riaz Bandali
President of Nordion2.8yrs데이터 없음데이터 없음
Jason Peterson
VP & Treasurerno data데이터 없음데이터 없음

4.1yrs

평균 재임 기간

54.5yo

평균 연령

경험이 풍부한 관리: SHC 의 관리팀은 경험 ( 4.1 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Michael Petras
Chairman & CEO8.4yrsUS$9.70m1.91%
$ 69.3m
James Neary
Independent Director4.1yrsUS$320.00k0.015%
$ 532.7k
Constantine Mihas
Independent Director4.1yrsUS$305.00k0.015%
$ 532.7k
Sean Cunningham
Independent Director4.1yrsUS$302.50k0.015%
$ 532.7k
Vincent Petrella
Independent Director4yrsUS$325.00k0.015%
$ 532.7k
Christopher Simon
Independent Directorless than a year데이터 없음데이터 없음
Ann Klee
Independent Director4.1yrsUS$322.50k0.031%
$ 1.1m
Robert Knauss
Independent Director2.1yrsUS$300.00k0.0056%
$ 201.5k
Ruoxi Chen
Independent Director4yrsUS$302.50k0.015%
$ 532.7k
David Wheadon
Independent Director3.5yrsUS$310.00k0.013%
$ 457.5k
Karen Flynn
Independent Directorless than a yearUS$9.99k데이터 없음

4.0yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: SHC 의 이사회경험(평균 재직 기간 4 년)으로 간주됩니다.